Susceptibilities of Yersinia pestis strains to 12 antimicrobial agents

Clicks: 322
ID: 116089
2000
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #52 of 105 articles by views in Antimicrobial agents and chemotherapy

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Ninety-two strains of Yersinia pestis recovered over a 21-year period were evaluated for susceptibility to traditional and newer antimicrobial agents. In vitro resistance was noted only against rifampin and imipenem (approximately 20% of strains). The most active compounds (MIC at which 90% of the i …
Reference Key
jd2000antimicrobialsusceptibilities Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Wong JD;Barash JR;Sandfort RF;Janda JM;;
Journal Antimicrobial agents and chemotherapy
Year 2000
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/10858370
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE animals humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't microbial sensitivity tests anti-bacterial agents / pharmacology* yersinia pestis / drug effects* cephalosporins / pharmacology pmid:10858370 pmc90001 doi:10.1128/aac.44.7.1995-1996.2000 j d wong j r barash j m janda cefixime / pharmacology ceftriaxone / pharmacology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.